Abstract:Objective To explore the mechanism of resveratrol in alleviating neuroinflammation after cerebral ischemia-reperfusion injury by inhibiting Toll like receptor 4 (TLR4) signaling pathway. MethodsSixty adult male SD rats were randomly divided into sham-operated group, cerebral ischemia-reperfusion injury group, and resveratrol treatment group (n=20). Rat models of transient middle cerebral artery occlusion (MCAO) in the latter two groups were prepared by modified thread embolization method; reperfusion was performed after 2 h of occlusion, and 20 mg/kg normal saline or resveratrol via tail vein injection was given 15 min before model preparation and one min before reperfusion, respectively. At 72 h after MACO, neurological severity scale (NSS) was applied to evaluate the neurological functions of rats. Enzyme linked immunosorbent assay was performed to detect the expressions of pro-inflammatory cytokines interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-αand anti-inflammatory cytokines IL-4, IL-10, and transforming growth factor (TGF)-β. Reverse transcription-polymerase chain reaction was performed to detect the mRNA expressions of M1 signature markersIL-1βandCD32and M2 signature markersCD206andArginase-1. Western blotting was used to detect the expressions of TLR4 signaling molecules TLR4, myeloid differentiation protein 88 (MyD88), tumor necrosis factor receptor-associated factor 6 (TRAF6), IL-1 receptor associated kinase 1 (IRAK1) and nuclear factor (NF)-κB.ResultsAs compared with those in the sham-operated group, rats in the cerebral ischemia-reperfusion injury group had significantly decreased NSS scores, significantly elevated levels of IL-1β, IL-6, TNF-α, IL-4, IL-10, and TGF-βin the damaged brain tissues, significantly elevated mRNA expression levels ofIL-1β,CD32,CD206, andArginase-1, and significantly elevated protein expression levels of TLR4, MyD88, TRAF6, IRAK1 and NF-κB (P<0.05). As compared with rats in the cerebral ischemia-reperfusion injury group, rats in the resveratrol treatment group had significantly decreased NSS scores, significantly decreased levels of IL-1β, IL-6, and TNF-α, significantly elevated levels of IL-4, IL-10, and TGF-βin the damaged brain tissues, significantly deceased mRNA expression levels ofIL-1βandCD32, significantly elevated mRNA expression levels of CD206andArginase-1, and significantly decreased protein expression levels of TLR4, MyD88, TRAF6, IRAK1 and NF-κB (P<0.05).ConclusionResveratrol inhibits microglia M1-type polarization and promotes M2-type polarization after cerebral ischemia reperfusion by inhibiting TLR4 signaling pathway, which further reduces neuroinflammation and neurological deficits.

Role and mechanism of resveratrol in a rat model of complex regional pain syndrome type Ⅰ

Effect of sciatic nerve pulsed radiofrequency glial activation levels in spinal dorsal horn in chronic constriction injury rat models and its analgesia effect

Pulsed Radiofrequency to the Dorsal Root Ganglion or the Sciatic Nerve Reduces Neuropathic Pain Behavior, Decreases Peripheral Pro-Inflammatory Cytokines and Spinal Β-Catenin in Chronic Constriction Injury Rats

Resveratrol Attenuates Inflammatory Hyperalgesia by Inhibiting Glial Activation in Mice Spinal Cords

Electroacupuncture Ameliorates Mechanical Allodynia of a Rat Model of CRPS-I Via Suppressing NLRP3 Inflammasome Activation in Spinal Cord Dorsal Horn Neurons

Activating Sirt1 by Resveratrol Suppresses Nav1.7 Expression in DRG Through Mir-182 and Alleviates Neuropathic Pain in Rats.

Resveratrol attenuates neuropathic pain through balancing pro-inflammatory and anti-inflammatory cytokines release in mice

Effect of resveratrol on inflammatory reaction after spinal cord injury in rats

Different-dosed glucocorticoid in treatment of tibial fracture rat model of complex regional pain syndrome type 1

Resveratrol Treatment of Spinal Cord Injury in Rat Model.

The Protective Effect of Resveratrol in the Transmission of Neuropathic Pain Mediated by the P2X7 Receptor in the Dorsal Root Ganglia.

Comparison of Two Methods for Establishing Rat Models of Complex Regional Pain Syndrome Type 1

Protective Effects of Resveratrol on Autologous Nucleus Pulposus Model of Radiculopathy.

Role of spinal dopamine D2 receptors in a rat model of neuropathic pain

Effects of resveratrol on motor function and anterior horn neuron of spinal cord following acute sciatic nerve compression injury in rats

Resveratrol inhibits paclitaxel-induced neuropathic pain by the activation of PI3K/Akt and SIRT1/PGC1α pathway

Mechanism of Resveratrol in Alleviating Neuroinflammation after Cerebral Ischemia Reperfusion by Inhibiting Toll Like Receptor 4 Signaling Pathway

Resolvin D1 alleviates mechanical allodynia via ALX/FPR2 receptor targeted NLRP3/ERK signaling in a neuropathic pain model

Analgesic and Anti-Inflammatory Activities of Resveratrol Through Classic Models in Mice and Rats

Resveratrol mediates mechanical allodynia through modulating inflammatory response via the TREM2-autophagy axis in SNI rat model

Chronic resveratrol treatment exerts antihyperalgesic effect and corrects co-morbid depressive like behaviors in mice with mononeuropathy: involvement of serotonergic system